📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional program. (2017)

First Author: Loughran SJ

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1084/jem.20161827

PubMed Identifier: 28899870

Publication URI: http://europepmc.org/abstract/MED/28899870

Type: Journal Article/Review

Volume: 214

Parent Publication: The Journal of experimental medicine

Issue: 10

ISSN: 0022-1007